Henwood Geraldine
- SEC CIK
- 0001236451
No open-market purchases or sales filed in the past year.
Current role at each company
- BXRX Baudax Bio, Inc.President and CEOas of Dec 19, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Henwood Geraldine as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2022 (view filing) | Dec 15 | 4 days | Henwood GeraldinePresident and CEO | PPurchase | +1.20K | $2.55 | +$3.06K | +97.8%2.43K after | |
| Sep 23, 2021 (view filing) | Sep 22 | 1 day | Henwood GeraldinePresident and CEO | PPurchase | +8.20K | $0.59 | +$4.84K | +2.3%364.5K after |